Close

Cocrystal Pharma, Inc. (COCP) Announces 26M Bought Deal Offering at $1.54/Sh

Go back to Cocrystal Pharma, Inc. (COCP) Announces 26M Bought Deal Offering at $1.54/Sh

Cocrystal Pharma Announces $40 Million Bought Deal Offering of Common Stock

May 4, 2021 6:41 PM EDT

BOTHELL, Wash., May 04, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (Cocrystal or the Company), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza... More